Tim Watkins, CMO & Head of Development: Contineum Therapeutics CTNM Sell · Filed 01/30

Trade details

Type: Insider sale
Amount: $39,452
Shares · price: 2,800 sh · $14.09 a share
Held after: 811 sh
Stock: Contineum Therapeutics CTNM
Person: Tim WatkinsCMO & Head of Development
Trade date: 26/01/28
Filed: 26/01/30
Days to filing: 2 days

Sold 77.5% of holdings

Share of holding sold: 77.5%

Contineum Therapeutics trades, last 26 weeks

What else happened in Contineum Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/29~02/27

Tim Watkins's recent trades

Tim WatkinsCMO & Head of Development
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$162.5K
10,833 sh
$162.5K
Filed 06/30
Traded 06/30
Tim WatkinsCMO & Head of Development
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$54.2K
3,611 sh
$54.2K
Filed 03/02
Traded 03/02
Tim WatkinsCMO & Head of Development
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$11.7K
811 sh
$11.7K
Filed 01/30
Traded 01/28
Tim WatkinsCMO & Head of Development
Sell10b5-1 planContineum Therapeutics
Sell10b5-1 plan
Contineum Therapeutics
CTNM
$43.5K
3,611 sh
$43.5K
Filed 25/12/30
Traded 25/12/29
Tim WatkinsCMO & Head of Development
Planned sale10b5-1 planContineum Therapeutics
Planned sale10b5-1 plan
Contineum Therapeutics
CTNM
$134.4K
10,833 sh
$134.4K
Filed 25/12/29
Traded 25/12/29

Tim Watkins, CMO — sold $39.5K of Contineum Therapeutics CTNM · 77.5% of holdings · 10b5-1 plan | Whalegun